This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
Cell & Gene Therapy Products 2020
Share |

Cell and Gene Therapy Products: Manufacturing, Quality and Regulatory Considerations

Updated March 19, 2020

CASSS leadership continues to monitor the ongoing impact of the COVID-19 (also known as coronavirus) outbreak for our attendees, exhibitors, and program partners. We are following the recommendations from the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), and will comply with any policies or restrictions issued by local government and city officials. This event is proceeding as planned. We will update the status of this meeting regularly.

About CGTP 2020

The CASSS Cell and Gene Therapy Products symposium enables the exchange of scientific ideas and dialogue with regulators that form the basis of evolving regulatory practices in the development of these diverse and innovative products. The CGTP 2020 Symposium will explore how to continue to adapt concepts applied to other biologics and how to establish novel approaches where they are needed.

CGTP Offers the Opportunity to:

• Gain and overall, in-depth understanding on what your peers are doing in the industry
• Hear updates on the latest regulatory trends
• Interactive forum to share experience with other cell and gene therapy experts from academia, industry, regulatory and vendors
• Obtain new ideas, tips and best practices


• Trends in Global CMC Regulatory
• Cell and Gene Therapy CQAs and Control Strategies
• Process Development, Characterization, and Validation
• Comparability for Cell and Gene Therapy Products
• Analytics for ATMPs
• Cell and Gene Therapy Product Manufacturing
• Allogeneic Cell Therapy Development
• CMC Considerations for Accelerated Development

Want more information? Check out the "More in this Section" dropdown box at the top of the page! 

Or contact CASSS at 510-428-0740 or



more Calendar

2/6/2020 » 4/30/2020
WCBP 2020 On-Demand

4/26/2020 » 4/28/2020
Bioassays 2020

5/11/2020 » 5/13/2020
CMC Strategy Forum Europe 2020

Featured Members
Membership Software Powered by YourMembership  ::  Legal